Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immix Biopharma, Inc.

2.97
+0.05001.71%
Post-market: 2.86-0.1058-3.56%19:53 EDT
Volume:278.84K
Turnover:831.49K
Market Cap:82.72M
PE:-4.24
High:3.04
Open:2.91
Low:2.91
Close:2.92
Loading ...
May 27, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 19, 2022

Major Issues Report

8-K - Current report
Jan 12, 2022

Major Issues Report

8-K - Current report
Jan 03, 2022

Major Issues Report

8-K - Current report
Dec 28, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2021

Major Issues Report

8-K - Current report
Dec 13, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 13, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 01, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 04, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 28, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 15, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 06, 2021

Correspondence

CORRESP [Cover] - Correspondence